These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 27135178

  • 1. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM.
    Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 3. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL, Roubey RAS, Kitzmiller KJ, Zhou D, Nagaraja HN, Mulvihill E, Barbar-Smiley F, Ardoin SP, Wu YL, Yu CY.
    Front Immunol; 2019 Oct; 10():885. PubMed ID: 31134052
    [Abstract] [Full Text] [Related]

  • 4. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 5. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yagüe J, Cervera R, Ingelmo M, Font J.
    Lupus; 2004 Mar; 13(10):777-83. PubMed ID: 15540510
    [Abstract] [Full Text] [Related]

  • 6. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
    Lonati PA, Scavone M, Gerosa M, Borghi MO, Pregnolato F, Curreli D, Podda G, Femia EA, Barcellini W, Cattaneo M, Tedesco F, Meroni PL.
    Front Immunol; 2019 Mar; 10():773. PubMed ID: 31031764
    [Abstract] [Full Text] [Related]

  • 7. Relationship of complement activation route with clinical manifestations in Japanese patients with systemic lupus erythematosus: a retrospective observational study.
    Watanabe H, Sugimoto M, Asano T, Sato S, Suzuki E, Takahashi A, Katakura K, Kobayashi H, Ohira H.
    Mod Rheumatol; 2015 Mar; 25(2):205-9. PubMed ID: 25036235
    [Abstract] [Full Text] [Related]

  • 8. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C, Schaarenburg RA, Beaart HJ, Huizinga TW, Steup-Beekman GM, Trouw LA.
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [Abstract] [Full Text] [Related]

  • 9. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W, Gryga K, Milewski M, Podolec M, Kostkiewicz M, Podolec P, Musial J.
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [Abstract] [Full Text] [Related]

  • 10. Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.
    Raymond W, Eilertsen G, Nossent J.
    J Immunol Res; 2018 Aug; 2018():8051972. PubMed ID: 30687766
    [Abstract] [Full Text] [Related]

  • 11. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
    Chen JL, Huang XM, Zeng XJ, Wang Y, Zhou MX, Ma YH, Li RS, Shen T.
    Zhonghua Yi Xue Za Zhi; 2007 May 22; 87(19):1330-3. PubMed ID: 17727778
    [Abstract] [Full Text] [Related]

  • 12. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A, Barr SG, Magder LS, Petri M.
    Arthritis Rheum; 2001 Oct 22; 44(10):2350-7. PubMed ID: 11665976
    [Abstract] [Full Text] [Related]

  • 13. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
    Charlesworth JA, Peake PW, Golding J, Mackie JD, Pussell BA, Timmermans V, Wakefield D.
    Ann Rheum Dis; 1989 Feb 22; 48(2):153-9. PubMed ID: 2784659
    [Abstract] [Full Text] [Related]

  • 14. Altered β2 -glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies.
    Mobarrez F, Gunnarsson I, Svenungsson E.
    J Thromb Haemost; 2017 Sep 22; 15(9):1799-1806. PubMed ID: 28667788
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.
    Li H, Lin S, Yang S, Chen L, Zheng X.
    Clin Rheumatol; 2015 Mar 22; 34(3):471-7. PubMed ID: 25597615
    [Abstract] [Full Text] [Related]

  • 16. The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies.
    Grosso G, Sandholm K, Antovic A, Gunnarsson I, Zickert A, Vikerfors A, Truedsson L, Bruzelius M, Nilsson B, Nilsson-Ekdahl K, Svenungsson E.
    Thromb Haemost; 2021 Oct 22; 121(10):1299-1309. PubMed ID: 33412597
    [Abstract] [Full Text] [Related]

  • 17. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct 22; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM.
    J Rheumatol; 2008 Sep 22; 35(9):1768-75. PubMed ID: 18634157
    [Abstract] [Full Text] [Related]

  • 19. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 22; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 20. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M, Todoroki T, Sakai K, Nobunaga M.
    J Rheumatol; 1981 Dec 22; 8(6):910-6. PubMed ID: 7328566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.